Drug-induced accelerated nodulosis: review of the literature

Int J Dermatol. 2023 Mar;62(3):432-440. doi: 10.1111/ijd.16549. Epub 2022 Dec 13.

Abstract

Accelerated nodulosis, the rapid progression/extension of preexisting nodules, is a recognized complication of immunomodulatory therapy, occurring mostly in patients with rheumatoid arthritis treated with methotrexate. As of today, its physiopathology remains incompletely understood, and there are no standardized guidelines regarding its management. Here, we conduct a literature review of the reported cases of drug-induced accelerated nodulosis and add our case of a 79-year-old female with an atypical clinical presentation.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Aged
  • Antirheumatic Agents* / therapeutic use
  • Arthritis, Rheumatoid* / drug therapy
  • Female
  • Humans
  • Methotrexate / therapeutic use
  • Rheumatoid Nodule* / chemically induced
  • Rheumatoid Nodule* / drug therapy
  • Rheumatoid Nodule* / pathology

Substances

  • Antirheumatic Agents
  • Methotrexate